We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Transport Medium Evaluated for Gut Bacterium

By LabMedica International staff writers
Posted on 30 Jan 2012
An alternative transport medium supplemented with a cyanobacterial extract (CE) has been evaluated for the preservation and viability of Helicobacter pylori strains. More...


The transport medium was free of animal derivatives, and was compared with other media during long-term transportation and the recovery of H. pylori from biopsy samples.

Microbiologists at the Universidad Nacional de San Luis (Argentina), collected four gastric antral biopsy specimens from 134 patients with gastroduodenal disease and were positive H. pylori infection. The transport media were based on an agar soft medium prepared with Mueller–Hinton broth 0.3% agar (MH) and 0.3% of CE (MH-CE). MH 5% fetal calf serum (FCS) was used as the reference medium (MH-FCS). Two gastric biopsy samples were placed into MH-CE or MH-FCS transport media and stored at 4 °C and at room temperature. Another biopsy sample was used for the urease test and polymerase chain reaction (PCR) identification. The remainder of the biopsy specimen was Gram stained. The diagnosis of H. pylori infection was established when two of three diagnostic methods, urease test, Gram or culture) were positive, followed by confirmation with PCR.

The recovery rate of H. pylori at 4 °C was similar among MH-CE and MH-FCS transport media between 24 to 72 hours, whereas a higher recovery was obtained with MH-CE after 96 and 120 hours. Only MH-CE allowed recovery after 120 hours. The H. pylori recovery at room temperature after 96 hour was higher in MH-CE than in MH-FCS. Similar survival rates were observed in biopsy samples conserved in MH-CE and MH-FCS at 4 °C. The recovery after 48 hours at room temperature in MH-CE was higher than MH-FCS and was the only medium allowing recovery after 72 hours. The viability of H. pylori strains stored within agar plugs in transport media and from biopsy specimens was assessed by viable count determinations (colony-forming units) on Mueller–Hinton agar supplemented with 7% horse blood (MHA-B) and direct fluorescence microscopy with the LIVE/DEAD BacLight Bacterial Viability Kit (Invitrogen Corporation, Eugene, OR, USA).

The authors concluded that MH-CE could be used as a transport medium to minimize the loss of bacterial viability when immediate culture or cool shipping is not possible. The transport medium proposed is simple to handle, inexpensive and complies with the present tendency of avoiding the use of animal derivatives. The study was published in the February 2012 edition of the European Journal of Clinical Microbiology and Infectious Diseases.

Related Links:
Universidad Nacional de San Luis
Invitrogen Corporation


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.